Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from CARGO Therapeutics, Inc. ( (CRGX) ).
On July 7, 2025, CARGO Therapeutics entered into a merger agreement with Concentra Biosciences, whereby Concentra will acquire CARGO for $4.379 in cash per share plus a contingent value right. The merger, expected to close in August 2025, has been unanimously approved by CARGO’s board as being in the best interests of its stockholders. The transaction includes a tender offer for all outstanding shares of CARGO common stock, with conditions such as the tender of a majority of shares and a minimum cash availability at closing. This acquisition positions CARGO to potentially enhance its market presence under Concentra’s ownership.
The most recent analyst rating on (CRGX) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on CARGO Therapeutics, Inc. stock, see the CRGX Stock Forecast page.
Spark’s Take on CRGX Stock
According to Spark, TipRanks’ AI Analyst, CRGX is a Underperform.
CARGO Therapeutics faces significant challenges with no revenue and increasing losses. The company’s decision to reduce workforce and pipeline efforts reflects financial distress. Although the technical indicators show some short-term upward momentum, the longer-term outlook remains weak. The negative valuation metrics further highlight profitability concerns. The strategic focus on CAR T therapy and potential partnerships may provide future opportunities but require careful financial management.
To see Spark’s full report on CRGX stock, click here.
More about CARGO Therapeutics, Inc.
CARGO Therapeutics, Inc. is a biotechnology company focused on developing CAR T-cell therapies for cancer patients.
Average Trading Volume: 642,514
Technical Sentiment Signal: Sell
Current Market Cap: $202.4M
Learn more about CRGX stock on TipRanks’ Stock Analysis page.